Dual antiplatelet therapy appears to be safe and effective in reducing stroke recurrence and combined vascular events in patients with acute ischemic stroke or transient ischemic attack as compared with mono therapy. These results need to be tested in prospective studies.
Authors: Chamila Geeganage, Hans‐Christoph Diener, Ale Algra, Christopher Chen, Eric J. Topol, Reinhard Dengler, Hugh S. Markus, Matthew W. Bath, Philip M. Bath
DOI: https://doi.org/10.1161/strokeaha.111.637686
Publish Year: 2012
